Bacterial septic arthritis in adults (Q37703722)

22 August 2017

1 reference

title

Bacterial septic arthritis in adults (English)

1 reference

22 August 2017

0 references

1 reference

Catherine J Mathews

1

1 reference

22 August 2017

Vivienne C Weston

2

1 reference

22 August 2017

Adrian Jones

3

1 reference

22 August 2017

Max Field

4

1 reference

22 August 2017

Gerald Coakley

5

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

375

1 reference

22 August 2017

issue

9717

1 reference

22 August 2017

page(s)

846-855

1 reference

A prospective 2-year study of 75 patients with adult-onset septic arthritis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Review of septic arthritis throughout the antibiotic era

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

An 18 year clinical review of septic arthritis from tropical Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Incidence and sources of native and prosthetic joint infection: a community based prospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Risk factors for septic arthritis in patients with joint disease. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Septic arthritis in haemodialysis patients: a seven-year multi-centre review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

No changes in the distribution of organisms responsible for septic arthritis over a 20 year period

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Osteoarticular bacterial infections are rare in HIV-infected patients. 14 cases found among 4,023 HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Osteoarticular and muscle infectious lesions in patients with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Septic arthritis due to Streptococcus pneumoniae in Nottingham, United Kingdom, 1985-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

HIV infection as a risk factor for septic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Model systems: modeling human staphylococcal arthritis and sepsis in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4-deficient mice depends on the genetic background of the host.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

The features of arthritis induced by CpG motifs in bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Surface protein adhesins of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Fulminant methicillin-sensitive Staphylococcus aureus infection in a healthy adolescent, highlighting 'Panton-Valentine leucocidin syndrome'

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Clinical features and aetiology of septic arthritis in northern Israel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Laboratory tests in adults with monoarticular arthritis: can they rule out a septic joint?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Use of BACTEC 9240 blood culture system for detection of Brucella melitensis in synovial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Use of the isolator 1.5 microbial tube for culture of synovial fluid from patients with septic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Acute monoarticular arthritis. A diagnostic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

The value of synovial fluid assays in the diagnosis of joint disease: a literature survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Diagnostic utility of laboratory tests in septic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Does this adult patient have septic arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Another look at synovial fluid leukocytosis and infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

How sensitive is the synovial fluid white blood cell count in diagnosing septic arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Gross synovial fluid analysis in the differential diagnosis of joint effusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Systematic review and meta-analysis of antibiotic therapy for bone and joint infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Linezolid for the treatment of adults with bone and joint infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

CTX-M: changing the face of ESBLs in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Septic arthritis due to extended spectrum beta lactamase producing Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Guideline for the management of the hot swollen joint in adults with a particular focus on septic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Treatment of septic arthritis: comparison of needle aspiration and surgery as initial modes of joint drainage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimentalStaphylococcus aureus-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

Regulatory role of interleukin-10 in experimental group B streptococcal arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-gamma and interleukin-10 production

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961595-6

7 January 2021

10.1016/S0140-6736(09)61595-6

Identifiers

DOI

1 reference

22 August 2017

1 reference